Since mid-2017 the UK has experienced a shortage of hepatitis B vaccine due to global manufacturing issues.
Summaries of the North West and Midlands GI and Liver Transformation and Sustainability Network
Entry deadline: 31st May 2018
Clinical guideline [CG131]
Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.